Bayer HealthCare Newswire

Bayer HealthCare Newswire

Comprehensive Real-Time News Feed for Bayer HealthCare.

Results 1 - 20 of 918 in Bayer HealthCare

  1. Monsanto Finally Licenses the Most Important Biotech Discovery of the 21st CenturyRead the original story w/Photo

    38 min ago | Fox News

    It's a wonder it took so long to plug. Perhaps senior management was caught up with a failed bid for Syngenta and its pending merger with Bayer .

    Comment?

  2. Record-breaker Totti must be cherished and what we learned in Europe this weekRead the original story w/Photo

    5 hrs ago | Goal.com

    The Roma veteran hit his 250th Serie A goal over the weekend after making his debut in 1993 and fans should take the time to appreciate his talents while he plays at the top level Much was made last week of celebrating Ronaldo's 40th birthday. The Brazilian icon and World Cup winner is one of four legendary players born in a golden period at the end of September 1976.

    Comment?

  3. German Lawmakers Critical Of Bayer-Monsanto Mega DealRead the original story

    Friday Sep 23 | Agri Marketing

    MONSANTO MEGA DEAL Sep. 23, 2016 Bloomberg reports: German lawmakers called on regulators to curb Bayer AG's $66 billion takeover of U.S. seed giant Monsanto Co. in a skepticism-laced parliamentary session that highlights the backlash to the deal Bayer faces in its home market.

    Comment?

  4. Mega mergers raise alarm over shrinking competitionRead the original story

    Thursday Sep 22 | The Western Producer

    A deal between potash giants Agrium and PotashCorp is just one of a handful of agricultural mega-mergers poised to go ahead. Last week, Bayer announced a friendly takeover bid for Monsanto for US$66 billion, the biggest in a string of recent merger announcements, following on the heels of the $59 billion Dow-DuPont deal and the $43 billion ChemChina-Syngenta deal.

    Comment?

  5. Monsanto Has No Power Here: EU's Food Safety CommissionerRead the original story w/Photo

    Thursday Sep 22 | Fox News

    If the deal goes through, the $66 billion mega-merger between Germany's Bayer and U.S.-based Monsanto could result in the world's largest supplier of genetically modified seeds - owning nearly one-fourth of the combined global market for seeds and pesticides. "I would like to say the rule for anti-monopoly in Europe is very strong.

    Comment?

  6. Bayer-Monsanto Deal Pilloried by Skeptical German LawmakersRead the original story

    Thursday Sep 22 | The Washington Post

    German lawmakers called on regulators to curb Bayer AG's $66 billion takeover of U.S. seed giant Monsanto Co. in a skepticism-laced parliamentary session that highlights the backlash to the deal Bayer faces in its home market.

    Comment?

  7. Bayer Sets Ambitious Growth And Earnings AspirationsRead the original story

    Thursday Sep 22 | Agri Marketing

    BAYER SETS AMBITIOUS GROWTH AND EARNINGS ASPIRATIONS Sep. 22, 2016 Source: Bayer news release The Bayer Group aims to achieve further growth in the coming years and is seeking higher sales and earnings in all businesses. "We are optimistic about Bayer's medium-term development and have therefore set ambitious aspirations," Management Board Chairman Werner Baumann said on Tuesday at the "Meet Management" investor conference in Cologne.

    Comment?

  8. Biotech Mergers Seen As Threat To U.S. FarmersRead the original story

    Wednesday Sep 21 | BioSpace

    The U.S. Senate Judiciary Committee grilled executives of the "Big Six" biotech companies Tuesday about what Chairman Charles Grassley, R-Iowa, called a tsunami of mergers that lawmakers say eliminates competition and raises prices on American farmers. Planned mergers involving U.S. biotech seed giants, such as Dow Chemical with Dupont/Pioneer and Monsanto with Bayer, could significantly increase seed costs for already struggling U.S. farmers, according to a study Sen. Ted.

    Comment?

  9. Russian Champions League sides dumped out of CupRead the original story w/Photo

    Wednesday Sep 21 | Channelnewsasia.com

    Russia's Champions League contenders suffered setbacks in their preparation for next week's group matches when they were knocked out of their domestic Cup by lower-league teams on Wednesday. Football Soccer - Bayer 04 Leverkusen v CSKA Moscow - Champions League - BayArena, Leverkusen, Germany - 14/9/16.

    Comment?

  10. Bayer and Luke Bryan Get Ready to Kick Up the Dust on Farm Tour 2016Read the original story w/Photo

    Wednesday Sep 21 | BroadwayWorld.com

    For the second straight year, Bayer is joining country music superstar Luke Bryan for the second straight year to bring his annual farm tour to eight cities across the U.S. Bryan, the son of a peanut farmer from Georgia, launched the tour in 2009 as a way to highlight and celebrate the contribution America's farmers make in putting food on tables in the United States and throughout the world. "I come from a farming background so I understand the hard work it takes for farmers to feed America and feed the world," said Luke Bryan.

    Comment?

  11. Bayer Mulls Dropping Monsanto Name as Brand Headache CureRead the original story

    Tuesday Sep 20 | The Washington Post

    With Bayer AG's proposed $66 billion purchase of Monsanto Co., the company that invented Aspirin is poised to take on one of the world's biggest corporate headaches. A potential cure: dropping the Monsanto name.

    Comment?

  12. Bayer Raises Peak Sales Forecast for New-Medicine PortfolioRead the original story

    Tuesday Sep 20 | The Washington Post

    Bayer AG raised the sales forecast for its latest blockbuster drugs, increasing optimism for the pharmaceutical unit as the German company pursues a $66 billion takeover of U.S. seeds giant Monsanto Co. A group of five new medicines including clot-busting Xarelto and eye treatment Eylea could generate more than 10 billion euros in annual revenue, up from a previous estimate of at least 7.5 billion euros, the Leverkusen-based conglomerate said in a statement on Tuesday.

    Comment?

  13. Europe Movers: Bayer, Kingfisher, GVC Holdings, IG Group, PennonRead the original story

    Tuesday Sep 20 | Ticker

    Kingfisher profit rose 1% and lifted annual profit forecast. GVC Holdings net swung to a loss but revenues surged.

    Comment?

  14. Bayer Raises Drug Sales Targets and Leaves Monsanto Combination TrailingRead the original story w/Photo

    Tuesday Sep 20 | TheStreet.com

    CEO Werner Baumann increases sales and margin forecasts for pharmaceuticals and insists Monsanto deal will deliver growth and improved profit. Bayer on Tuesday sought to reassure investors of the wisdom of its $66 billion acquisition of Monsanto but may have succeeded in doing the opposite as it unveiled impressive new growth and profitability projections for its pharmaceuticals operations.

    Comment?

  15. Bayer sets ambitious growth and earnings aspirations, expects new...Read the original story w/Photo

    Tuesday Sep 20 | Seeking Alpha

    The Bayer Group aims to achieve further growth in the coming years and is seeking higher sales and earnings in all businesses. Management Board Chairman Werner Baumann said, "We anticipate especially significant sales and margin growth at Pharmaceuticals.

    Comment?

  16. Bloomberg: Bayer may drop Monsanto name as brand headache cureRead the original story w/Photo

    Tuesday Sep 20 | Seeking Alpha

    Bayer is considering dropping the name of Monsanto in its $66B purchase to avoid sullying its reputation, according to a Bloomberg report. While MON is known for making the herbicide Agent Orange used in the Vietnam War and tangling with environmental groups over genetically modified crops, Bayer brought Aspirin to market in 1899 and this year topped a ranking of the world's most reputable pharmaceutical brands from the Reputation Institute marketing firm.

    Comment?

  17. Bayer ups forecasts after Monsanto takeover dealRead the original story w/Photo

    Tuesday Sep 20 | West Australian

    German chemicals giant Bayer said Tuesday it had increased its earnings and profits forecasts after signing a deal to take over US seeds and pesticides maker Monsanto. "We are optimistic for the medium-term development of Bayer and have set ourselves correspondingly ambitious targets," chief executive Werner Baumann said in a statement.

    Comment?

  18. Bayer sets out 'ambitious' sales, profit targetsRead the original story w/Photo

    Monday Sep 19 | MarketWatch

    German pharmaceuticals and chemicals group Bayer AG said Tuesday it is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $66 billion takeover of U.S. seed company Monsanto Co. "We are optimistic about Bayer's medium-term development and have therefore set ambitious aspirations," said Chief Executive Werner Baumann, ahead of an event for investors and analysts in Cologne.

    Comment?

  19. Bayer Sets Out Improved Sales, Profitability ForecastsRead the original story w/Photo

    Monday Sep 19 | Wall Street Journal

    German pharmaceuticals and chemicals group Bayer AG said Tuesday it is targeting increased sales and earnings growth over the next few years at its drug and crop-science businesses, just days after announcing a planned $66 billion takeover of U.S. seed company Monsanto Co.

    Comment?

  20. Bayer ups sales targets for top-selling drugs after Monsanto dealRead the original story w/Photo

    Monday Sep 19 | Reuters

    The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014. ) said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto for stroke prevention pill Xarelto, jointly sold with Johnson & Johnson , it now sees peak sales potential of more than EUR 2.5 billion, up from at least 1.5 billion euros previously.

    Comment?